Speights VO - Search Results

1

Hypermethylation of the caveolin-1 gene promoter in prostate cancer.

Cui J, Rohr LR, Swanson G, Speights VO, Maxwell T, Brothman AR. Cui J, et al. Among authors: speights vo. Prostate. 2001 Feb 15;46(3):249-56. doi: 10.1002/1097-0045(20010215)46:3<249::aid-pros1030>3.0.co;2-#. Prostate. 2001. PMID: 11170154

2

Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome?

Brothman AR, Swanson G, Maxwell TM, Cui J, Murphy KJ, Herrick J, Speights VO, Isaac J, Rohr LR. Brothman AR, et al. Among authors: speights vo. Cancer Genet Cytogenet. 2005 Jan 1;156(1):31-6. doi: 10.1016/j.cancergencyto.2004.04.004. Cancer Genet Cytogenet. 2005. PMID: 15588853

3

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

Cuzick J, Swanson GP, Fisher G, Brothman AR, Berney DM, Reid JE, Mesher D, Speights VO, Stankiewicz E, Foster CS, Møller H, Scardino P, Warren JD, Park J, Younus A, Flake DD 2nd, Wagner S, Gutin A, Lanchbury JS, Stone S; Transatlantic Prostate Group. Cuzick J, et al. Among authors: speights vo. Lancet Oncol. 2011 Mar;12(3):245-55. doi: 10.1016/S1470-2045(10)70295-3. Lancet Oncol. 2011. PMID: 21310658 Free PMC article.

4

Gleason Score Evolution and the Effect on Prostate Cancer Outcomes.

Swanson GP, Trevathan S, Hammonds KAP, Speights VO, Hermans MR. Swanson GP, et al. Among authors: speights vo. Am J Clin Pathol. 2021 Apr 26;155(5):711-717. doi: 10.1093/ajcp/aqaa130. Am J Clin Pathol. 2021. PMID: 33079976

5

Failure of Ploidy and Proliferative Fraction to Predict Long-Term Outcome After Prostatectomy.

Swanson GP, Chen W, Speights VO. Swanson GP, et al. Among authors: speights vo. World J Oncol. 2018 Jun;9(3):69-73. doi: 10.14740/wjon1111w. Epub 2018 Jun 26. World J Oncol. 2018. PMID: 29988804 Free PMC article.

6

Differential expression of insulin-like growth factor binding proteins in high versus low Gleason score prostate cancer.

Figueroa JA, De Raad S, Tadlock L, Speights VO, Rinehart JJ. Figueroa JA, et al. Among authors: speights vo. J Urol. 1998 Apr;159(4):1379-83. J Urol. 1998. PMID: 9507888

7

Gene expression of insulin-like growth factors and receptors in neoplastic prostate tissues: correlation with clinico-pathological parameters.

Figueroa JA, De Raad S, Speights VO, Rinehart JJ. Figueroa JA, et al. Among authors: speights vo. Cancer Invest. 2001;19(1):28-34. doi: 10.1081/cnv-100000072. Cancer Invest. 2001. PMID: 11291553

8

Prostatic acid phosphatase levels (enzymatic method) from completely sectioned, clinically benign, whole prostates.

Brawn PN, Jay DW, Foster DM, Kuhl D, Speights VO, Johnson EH, Riggs M, Lind ML, Coffield KS, Weaver B. Brawn PN, et al. Among authors: speights vo. Prostate. 1996 May;28(5):295-9. doi: 10.1002/(SICI)1097-0045(199605)28:5<295::AID-PROS4>3.0.CO;2-B. Prostate. 1996. PMID: 8610055

9

Serum prostate-specific antigen levels in stage A1 prostatic cancer.

Cohen MK, Riggs MW, Brawn PN, Spiekerman AM, Speights VO. Cohen MK, et al. Among authors: speights vo. Am J Clin Pathol. 1993 Aug;100(2):127-9. doi: 10.1093/ajcp/100.2.127. Am J Clin Pathol. 1993. PMID: 7689292

10

Use of age-specific normal ranges for serum prostate-specific antigen.

Slovacek KJ, Riggs MW, Spiekerman AM, Speights VO Jr. Slovacek KJ, et al. Among authors: speights vo jr. Arch Pathol Lab Med. 1998 Apr;122(4):330-2. Arch Pathol Lab Med. 1998. PMID: 9648900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters